Press Releases

Huateng Pharma Supplies Semaglutide Intermediates Against Type 2 Diabetes

Genezen appoints Chief Commercial Officer to Executive Leadership Team

Genezen appoints Jeff Whitmore as CCO

Andelyn Biosciences to Manufacture First Gene Therapy for Infantile Neuroaxonal Dystrophy in the US

Creative Enzymes Expands Its Service Offering with the Launch of Custom Enzyme Blends

Creative Enzymes Provides DNA Molecular Weight Markers and Ladders

CD Genomics Expands Its Sequencing Portfolio with the Launch of Whole Exome Sequencing

MicrobioSeq Boosts Scientific Research with Gene Expression Analysis

Micro-Sphere Launches New Research & Development Services at Swiss Site

Global contract development and manufacturing organisation (CDMO) Micro-Sphere has launched a new, 200 square-foot research and development (R&D) lab to strengthen its services in formulation development and inhalation.

Zebrafish Disease Model: Developed by Creative Biogene to Support Multiple Therapeutic Areas

IntegrateRNA Develops Premade Circular RNA Products to Satisfy Various Downstream Applications

Microbiosci Develops Data-independent Acquisition Proteomics to Support Molecular Diagnostics

Creative Bioarray Develops More Than 1000 Cell Types Together with Selective Cell Culture Media

Creative Bioarray Releases GMP Grade Cytokines to Support Cell Manufacturing and Cell-based Therapies

Acroscell Develops CiPA in Silico Modeling to Identify and Optimize Drug Candidates

Chantal van Gils joins NDA Advisory Board as Director of Epidemiology and Real-World Evidence

NDA Group has announced that Chantal van Gils NDA, MD, Ph.D., specialist in epidemiological analyses and outcome research, joins the NDA Advisory Board as Director of Epidemiology and Real-World Evidence.

uMotif Announces First New Validated Innovation in eCOA/ePRO Since Paper Instruments Were Deployed on Smartphones

uMotif's patent-protected Motif data capture interface is proven as an equivalent method to capture Patient Reported Outcome and eDiary data, eliminating reliance on text-based instruments, in a study with 55 participants in 2 randomized groups conducted by SAFIRA Clinical Research at Dublin City University

Clinion Achieves GDPR Compliance, continuing its commitment to data privacy and security

Clinion is pleased to announce that its AI-enabled eClinical platform is fully compliant with the General Data Protection Regulation (GDPR)

Pharma Supply Chain & Security World 202

“Supply-Chain, Drug Serialization, Packaging & Labelling and Anti-Counterfeiting” Conference, Expo and Workshop

Viz.ai and Vastrax Join Forces to Accelerate Clinical Trial Enrollment

Calyx Medical Imaging Advances Neuro-oncology Treatment Development through AI

Partnership with Neosoma enables faster, more precise tumor assessment in glioblastoma research